Prevention And Treatment Of Degenerative Diseases By Glutathione And Phase Ii Detoxification Enzymes

Abstract

The present invention generally relates to the field of treating degenerative disease by administering a pharmaceutically effective amount of a compound that elevates glutathione or at least one Phase II detoxification enzyme in diseased tissue. The present invention also relates to a pharmaceutical composition useful for the treatment of degenerative diseases, as well as a method of identifying agents that modulate intracellular levels of glutathione or intracellular levels of at least one Phase II enzyme in neuronal cells.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 2, 2004
  • Application: Jul 5, 2001
    US US 89793401 A
  • Priority: Jul 5, 2001
    US US 89793401 A
  • Priority: Jul 5, 2000
    US US 21581200 P

Sign in to the Lens

Feedback